Zefrox-CV 325: Combating Bacterial Infections with Precise Targeting

Zefrox-CV 325 Tablet is a powerful, once-daily antibiotic designed to treat a wide range of bacterial infections. It combines the effectiveness of cefpodoxime proxetil (200mg) and clavulanic acid (125mg). This specific combination provides effective treatment for both Gram-positive and some Gram-negative bacteria.

Cefpodoxime proxetil, the first-line ingredient in Zefrox-CV 325, effectively inhibits bacterial cell wall synthesis. The addition of clavulanic acid acts as a beta-lactamase inhibitor, preventing breakdown by certain bacteria that produce this enzyme. This synergistic action ensures optimal antibacterial activity against even drug-resistant strains.

Zefrox-CV 325 is indicated for the treatment of various infections like upper and lower respiratory tract infections, otitis media, bronchitis, sinusitis, and urinary tract infections (UTIs). Its convenient dosage form and targeted approach make it an effective choice for both healthcare professionals and patients alike.

Always consult your doctor or pharmacist before using any medication.